Systematic Review and Cumulative Analysis of the Combination of Mitomycin C plus Bacillus Calmette-Guérin (BCG) for Non–Muscle-Invasive Bladder Cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-03421-5.pdf
Reference46 articles.
1. Jemal, A. et al. Cancer statistics. CA Cancer J Clin 59, 225–249 (2009).
2. Lum, B. L. & Torti, F. M. Adjuvant intravesicular pharmacotherapy for superficial bladder cancer. J Natl Cancer Inst 83, 682–694 (1991).
3. Rosenberg, J. E., Carroll, P. R. & Small, E. J. Update on chemotherapy for advanced bladder cancer. J Urol. 174, 14–20 (2005).
4. Hsieh, J. T., Dinney, C. P. & Chung, L. W. The potential role of gene therapy in the treatment of bladder cancer. Urol Clin North Am 27, 103–113 (2000).
5. Malmstrom, P. U. et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guerin for non-muscle-invasive bladder cancer. Eur Urol. 56, 247–256 (2009).
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Fraxetin inhibits proliferation and induces apoptosis of bladder cancer through the Akt pathway in vitro and in vivo;Journal of Biochemical and Molecular Toxicology;2023-10-23
2. A new catheter-integrated drug-delivery system for controlled intravesical mitomycin C release;Urologic Oncology: Seminars and Original Investigations;2022-09
3. Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril® Soft Gels) for the Prevention of LUTS after Intravesical Chemotherapy;Pathophysiology;2022-07-13
4. Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer;Science Translational Medicine;2021-01-06
5. Robotic cystectomy histopathology outcomes in patients who have ‘failed’ Bacillus Calmette–Guérin: A case series;Journal of Clinical Urology;2021-01-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3